beta-innov.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Disallow: /wp-includes/ | ||
Meta Tags
| Title | Beta Innov - Maladies auto-immunes et |
| Description | Innovation Mise au point de nouveaux médicaments à but curatif en Immunologie et |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 109.234.161.18 |
| Location | France |
Related Websites
| Site | Rank |
More to Explore
beta-innov.com Valuation
|
US$356,246
Last updated: 2022-11-25 14:40:44
beta-innov.com has Semrush global rank of 29,710,714. beta-innov.com has an estimated worth of US$ 356,246, based on its estimated Ads revenue. beta-innov.com receives approximately 41,106 unique visitors each day. Its web server is located in France, with IP address 109.234.161.18. According to SiteAdvisor, beta-innov.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$356,246 |
| Daily Ads Revenue | US$329 |
| Monthly Ads Revenue | US$9,866 |
| Yearly Ads Revenue | US$118,384 |
| Daily Unique Visitors | 2,741 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| beta-innov.com. | A | 86400 | IP: 109.234.161.18 |
| beta-innov.com. | NS | 21600 | NS Record: dns200.anycast.me. |
| beta-innov.com. | NS | 21600 | NS Record: ns200.anycast.me. |
| beta-innov.com. | MX | 21600 | MX Record: 10 mail.tutanota.de. |
| beta-innov.com. | TXT | 86400 | TXT Record: v=spf1 include:spf.tutanota.de -all |
HtmlToTextCheckTime:2022-11-25 14:40:44
| Beta Innov --> Maladies auto-immunes et glioblastome L’équipe L’équipe scientifique Direction Scientifique Direction Exécutive R & D Etat actuel de l’art Immunologie Glioblastome Partenariats Publications Comité Scientifique Investisseurs À Propos Notre actualité Contact Newsletter Plan du site Innovation Innovation « D’un statut initial de start-up à celui d’une société de développement préclinique, Beta Innov se consacre au développement de thérapies innovantes avec un projet structuré, cohérent, et des preuves de concept solides. » Mise au point de nouveaux médicaments à but curatif en Immunologie et Cancérologie . Beta Innov SAS est une entreprise de Recherche et Développement pharmaceutique, créée en mars 2009 par des familles de patients. Beta Innov conduit deux projets de recherche qui ont pour objectif de réaliser une avancée thérapeutique majeure dans le traitement de maladies auto immunes et du Glioblastome. Les approches scientifiques retenues sont protéomiques en |
HTTP Headers
HTTP/1.1 302 Moved Temporarily Date: Wed, 22 Jun 2022 08:42:23 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 0 Connection: keep-alive Location: http://www.beta-innov.com/ Referrer-Policy: Server: o2switch-PowerBoost-v3 HTTP/1.1 200 OK Date: Wed, 22 Jun 2022 08:42:23 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 29585 Connection: keep-alive Vary: Accept-Encoding Last-Modified: Tue, 21 Jun 2022 14:28:01 GMT Referrer-Policy: Server: o2switch-PowerBoost-v3 Accept-Ranges: bytes |
beta-innov.com Whois Information
Domain Name: BETA-INNOV.COM Registry Domain ID: 1540157527_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ovh.com Registrar URL: http://www.ovh.com Updated Date: 2022-01-10T01:49:15Z Creation Date: 2009-01-31T17:45:17Z Registry Expiry Date: 2023-01-31T17:45:17Z Registrar: OVH sas Registrar IANA ID: 433 Registrar Abuse Contact Email: abuse@ovh.net Registrar Abuse Contact Phone: +33.972101007 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS200.ANYCAST.ME Name Server: NS200.ANYCAST.ME DNSSEC: signedDelegation DNSSEC DS Data: 49747 8 2 D26701C2DF7A9326CBF69C736C6163EF240FE28B22A91BD48C7100B6A8EA3874 >>> Last update of whois database: 2022-06-22T08:36:26Z <<< |